Bristol-Myers Squibb (NYSE:BMY) SVP John E. Elicker sold 9,534 shares of the stock on the open market in a transaction dated Wednesday, February 19th. Bristol-Myers Squibb Co (NYSE:BMY) stock opened at $54.23 in last session, and closed at $53.46, while the day range of stock is $53.42 – $ 54.62. The stock showed a positive weekly performance of 1.60%.
A lung cancer drug in testing by Eli Lilly and Co. (NYSE:LLY) performed well in a late-phase patient trial. Eli Lilly & Co. (NYSE:LLY) stock opened at $57.30, in last session and closed at $58.09, by gaining 5.14 %. The 52 week range of the stock is $47.53 – $ 58.40. Company’s market capitalization is $65.45 billion.
Abbott Laboratories (NYSE:ABT) has been on the receiving end on one of its drugs, AndroGel. Apparently, five men have filed lawsuits against Abbott Laboratories (NYSE:ABT) and its recently formed subsidiary – AbbVIE Inc, for not revealing the dangers of the drug which essentially worked as a replacement for testosterone. Abbott Laboratories (NYSE:ABT) stock decreased -0.44% and finished the last session at $38.76. The EPS of the stock remained 1.52. Company’s market capitalization is $59.93 billion.
Teva Pharmaceutical Industries (NASDAQ:TEVA) was the recipient of unusually large options trading activity on Wednesday. Stock investors purchased 199,973 call options on the company, AnalystRatingsNetwork.com reports. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock opened the session at $45.37, and closed the session at $46.74. The 52 week range of the stock remained $36.26 – $ 47.79 and the day range was $45.37 – $ 47.79.